Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)

Clinical Trial ID NCT00002540

PubWeight™ 143.85‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00002540

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011 38.61
2 Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009 30.05
3 Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012 11.91
4 Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012 11.48
5 Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 2011 9.13
6 Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011 6.45
7 Performance of common genetic variants in breast-cancer risk models. N Engl J Med 2010 5.79
8 Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol 2010 4.84
9 Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol 2009 3.59
10 Utilization of surveillance colonoscopy in community practice. Gastroenterology 2009 3.33
11 Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2010 2.38
12 Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011 2.31
13 Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med 2009 1.94
14 Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer. Clin Gastroenterol Hepatol 2012 1.44
15 Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology 2015 1.40
16 Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. Am J Clin Nutr 2014 1.35
17 Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst 2010 1.29
18 Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst 2012 1.27
19 Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer 2009 1.22
20 Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol 2010 1.21
21 Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. J Thorac Oncol 2009 1.03
22 Ovarian cancer screening in women with a family history of breast or ovarian cancer. Obstet Gynecol 2006 0.99
23 The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context. Acta Oncol 2011 0.92
24 Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. Am J Clin Nutr 2015 0.88
25 Factors associated with human small aggressive non small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2007 0.87
26 Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer. J Nutr 2014 0.83
27 Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiol 2012 0.81
28 Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up. Gynecol Oncol 2016 0.79
29 Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial. Lung Cancer 2013 0.75
30 Interval lung cancers not detected on screening chest X-rays: How are they different? Lung Cancer 2014 0.75
Next 100